ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 084,63
-0,70%
Dow Jones
39 872,99
0,00%
DAX
18 665,50
-0,32%
Brent Oil
82,015
-0,52%
Bitcoin
69 813,18
-0,45%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Amylin Pharmaceuticals, Inc. (MM) (AMLN)

  7. Amylin Pharmaceuticals, Inc. (MM) (AMLN) Actualités

AMLN

Amylin Pharmaceuticals, Inc. (MM) (AMLN)

Amylin Pharmaceuticals, Inc. (MM)
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:AMLN
DateHeureSourceTitreSymboleSociété
09/08/201214h24Dow Jones NewsAstraZeneca: Bristol-Myers Squibb Completes Purchase of AmylinNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
08/08/201222h11Edgar (US Regulatory)(25-NSE)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
08/08/201215h19Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
08/08/201214h40Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
03/08/201222h26Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
03/08/201200h03Dow Jones News2nd UPDATE: Bristol-Myers Executive Charged With Insider TradingNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
02/08/201220h00Dow Jones NewsUPDATE: Bristol-Myers Executive Charged With Insider TradingNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
02/08/201218h30Dow Jones NewsBristol-Myers Executive Charged With Insider TradingNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
02/08/201218h17Dow Jones NewsU.S. Charges Bristol-Myers Executive With Insider TradingNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
02/08/201217h07Dow Jones NewsBristol-Myers Pension Executive Robert Ramnarine Arrested for Alleged Insider Trading -BloombergNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
01/08/201213h30Business WireBristol-Myers Squibb Announces Expiration of the Hart-Scott-Rodino Waiting Period for Acquisition of Amylin Pharmaceuticals, ...NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
31/07/201219h32ZacksSolid Quarter at ALKS, View Backed - Analyst BlogNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
30/07/201222h23Edgar (US Regulatory)Statement of Ownership (SC 13G)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
27/07/201202h08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
26/07/201216h24Dow Jones NewsEvercore 2nd-Quarter Profit Climbs 19% On Higher Investment Banking RevenueNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
25/07/201214h20Dow Jones NewsBristol-Myers Profit Falls 28%NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
25/07/201214h00Dow Jones NewsBristol-Myers 2nd-Quarter Profit Falls 28% on Drug-Patent ExpirationsNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
25/07/201211h39ZacksGeneric Plavix Hurts Bristol-Myers - Analyst BlogNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
23/07/201215h30ZacksEarnings Preview: Bristol-Myers - Analyst BlogNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
17/07/201220h10ZacksTPG to Acquire Par Pharma for $1.9B - Analyst BlogNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
12/07/201221h05Dow Jones NewsUPDATE: Icahn Appeals to Nonmanagement Directors at Forest LabsNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
12/07/201200h10Business WireThe Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Amylin...NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
11/07/201219h03ZacksBristol-Myers/AMLN Deal Progresses - Analyst BlogNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
10/07/201218h01PR Newswire (US)Block & Leviton LLP Investigates Amylin Pharmaceuticals, Inc. for Possible Breaches of Fiduciary Duties in Connection with It...NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
10/07/201214h06Edgar (US Regulatory)Tender offer statement by Third Party (SC TO-T)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
10/07/201213h30Business WireBristol-Myers Squibb Begins Tender Offer to Acquire Amylin Pharmaceuticals, Inc.NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
10/07/201211h15ZacksAlkermes Upped to Outperform - Analyst BlogNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
09/07/201218h51PR Newswire (US)Securities Lawyers at Goldfarb LLP Seeking More Money, Information for Stockholders of Amylin Pharmaceuticals, Inc.NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
07/07/201215h00Business WireLaw Office of Brodsky & Smith, LLC Announces Investigation of Amylin Pharmaceuticals, Inc.NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
06/07/201214h53Edgar (US Regulatory)Written communication by the subject company relating to a third party tender offer (SC14D9C)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
 Showing the most relevant articles for your search:NASDAQ:AMLN

Dernières Valeurs Consultées

TG
ITH
Nektar Therapeutics
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés